Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print January 28, 2005, 10.1148/radiol.2343031440

(Radiology 2005;234:833.)

A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow All Versions of this Article:
2343031440v1
234/3/833    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumgartner, I.
Right arrow Articles by Kreis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgartner, I.
Right arrow Articles by Kreis, R.
© RSNA, 2005

Molecular Imaging

Leg Ischemia: Assessment with MR Angiography and Spectroscopy1

Iris Baumgartner, MD, Harriet C. Thoeny, MD, Oliver Kummer, MD, Christian Roefke, MD, Corinna Skjelsvik, MD, Chris Boesch, MD, PhD and Roland Kreis, PhD

1 From the Swiss Cardiovascular Center, Division of Angiology (I.B., O.K., C.S.) and Departments of Diagnostic, Interventional, and Pediatric Radiology (H.C.T., C.R.), University Hospital Bern, Freiburgstrasse 10, 3010 Bern, Switzerland; and Department for Clinical Research (MR Spectroscopy and Methodology), University of Bern, Bern, Switzerland (C.B., R.K.). Received September 8, 2003; revision requested November 20; final revision received June 23, 2004; accepted June 29. Supported by the Swiss National Science Foundation (4037–055161, 3100–065315, 3100059082). Address correspondence to H.C.T. (e-mail: harriet.thoeny@insel.ch).

PURPOSE: To prospectively determine reproducibility of magnetic resonance (MR) angiography and MR spectroscopy of deoxymyoglobin in assessment of collateral vessels and tissue perfusion in patients with critical limb ischemia (CLI) and to follow changes in patients undergoing intramuscular vascular endothelial growth factor (pVEGF)-C gene therapy, percutaneous transluminal angioplasty, supervised exercise training, or no therapy.

MATERIALS AND METHODS: Study and gene therapy protocols were approved, and all patients gave written informed consent. To determine repeatability and reproducibility, seven patients underwent MR angiography and five underwent MR spectroscopy. The techniques were used to judge disease progress in 12 other patients with or without therapy: MR angiography to help determine change in visualization of collateral vessels and MR spectroscopy to help assess change in perfusion at proximal and distal calf levels. MR angiographic results were subjectively analyzed by three blinded readers. Intraobserver variability was expressed as 95% confidence interval (CI) (n = 7); interobserver variability, as {kappa} statistic (n = 15). Reexamination variability of MR spectroscopy was given as 95% CI for subsequent recovery times, and correlation with disease extent was calculated with Kendall {tau}b rank correlation. Fisher-Yates test was used to correlate changes with pressure measurements and clinical course.

RESULTS: Intraobserver and interobserver concordance was sensitive for detection of collateral vessels. Intraobserver agreement was 85.7% (95% CI: 42.1%, 99.6%). Interobserver agreement was high for small collateral vessels ({kappa} = 0.74, P < .001) and fair for large collateral vessels ({kappa} = 0.36, P = .002). MR spectroscopy was reproducible (95% CI: ±26 seconds for proximal, ±21 seconds for distal) and showed a correlation with disease extent (proximal calf, {tau}b = 0.84, P < .001; distal calf, {tau}b = 0.68, P = .04). Small collateral vessels increased over time (P = .04) but did not correlate with pressure measurements and clinical course. Recovery time correlated with clinical course (proximal calf, P = .03; distal calf, P = .005).

CONCLUSION: MR angiography and MR spectroscopy of deoxymyoglobin can help document changes in visualization of collateral vessels and tissue perfusion in patients with CLI.

© RSNA, 2005




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
K. I. Paraskevas, T. T. Papas, P. Pavlidis, N. Bessias, and V. Andrikopoulos
The Importance of Conservative Measures in Peripheral Arterial Disease: An Update
Angiology, October 1, 2008; 59(5): 529 - 533.
[PDF]


Home page
JNMHome page
I. Penuelas, X. L. Aranguren, G. Abizanda, J. M. Marti-Climent, M. Uriz, M. Ecay, M. Collantes, G. Quincoces, J. A. Richter, and F. Prosper
13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease
J. Nucl. Med., July 1, 2007; 48(7): 1216 - 1223.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.